Publications @ the Tavernier Group
- Zabeau, L. et al. Leptin’s metabolic and immune functions can be uncoupled at the ligand/receptor level. Cell Mol Life Sci 72: 629-644 (2015).
- Peelman, F. et al. 20 years of leptin. Insights into signaling assemblies of the leptin receptor. Journal of Endocrinology 223:T9-T23 (2014).
- Garcin, G. et al. High efficiency cell-specific targeting of cytokine activity. Nature Communications 5: 3016 (2014).
- Lievens, S. et al. KISS, a mammalian in situ protein interaction sensor. Mol Cell Proteomics 13: 3332-3342 (2014).
- Rolland, T. et al. A proteome-scale map of the human interactome network. Cell 159: 1212-1226 (2014).
- YIPF2 is a novel Rab-GDF that enhances HCC malignant phenotypes by facilitating CD147 endocytic recycle.
- The Small GTPase Arf6: An Overview of Its Mechanisms of Action and of Its Role in Host⁻Pathogen Interactions and Innate Immunity.
- Control of anterior GRadient 2 (AGR2) dimerization links endoplasmic reticulum proteostasis to inflammation.
- Straightforward Protein-Protein Interaction Interface Mapping via Random Mutagenesis and Mammalian Protein Protein Interaction Trap (MAPPIT).
- Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation.
- Protein complex analysis: From raw protein lists to protein interaction networks.
- A novel leptin receptor antagonist uncouples leptin’s metabolic and immune functions.
- Targeting interferon activity to dendritic cells enables in vivo tolerization and protection against EAE in mice.
- Nanoparticle-Conjugate TLR7/8 Agonist Localized Immunotherapy Provokes Safe Antitumoral Responses.
- Modifying Rap1-signalling by targeting Pde6δ is neuroprotective in models of Alzheimer’s disease.